The DLC-1 -29A/T polymorphism is not associated with nasopharyngeal carcinoma risk in Chinese population

Genetic Testing

Volumn 12, Issue 3, 2008, Pages 345-349

  Feng, Xiang Ling ^a   Zhou, Wen ^a   Li, Hong ^a   Fang, Wei Yi ^b   Zhou, Yi Bo ^a   Yao, Kai Tai ^a,b   Ren, Cai Ping ^a  

^a Central South University   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGED; ARTICLE; CANCER GENETICS; CANCER RISK; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PROMOTER REGION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA; CASE-CONTROL STUDIES; CHINA; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; POPULATION GROUPS; RISK FACTORS; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 50649105971     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2007.0121     Document Type: Article

References (29)

1. Chow LS, Lo KW, Kwong J, et al. (2004) RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. Int J Cancer 109(6):839-847.
2. Dammann R, Strunnikova M, Schagdarsurengin U, et al. (2005) CpG island methylation and expression of tumour-associated genes in lung carcinoma. Eur J Cancer 41(8):1223-1236.
3. Durkin ME, Avner MR, Huh CG, et al. (2005) DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development. FEBS Lett 579(5):1191-1196.
4. Guan M, Zhou X, Soulitzis N, et al. (2006) Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications. Clin Cancer Res 12(5):1412-1419.
5. Hromas R, Morris J, Cornetta K, et al. (1995) Aberrant expression of the myeloid zinc finger gene, MZF-1, is oncogenic. Cancer Res 55(16):3610-3614.
6. Kim TY, Jong HS, Song SH, et al. (2003) Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. Oncogene 22(25):3943-3951.
7. Kim TY, Lee JW, Kim HP, et al. (2007) DLC-1, a GTPaseactivating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma. Biochem Biophys Res Commun 355(1):72-77.
8. Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68(4):820-823.
9. Liu XQ, Chen HK, Zhang XS, et al. (2003) Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma. Int J Cancer 106(1):60-65.
10. Lo KW, To KF, Huang DP (2004) Focus on nasopharyngeal carcinoma. Cancer Cell 5(5):423-428.
11. Lung HL, Cheng Y, Kumaran MK, et al. (2004) Fine mapping of the 11q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma. Int J Cancer 112(4):628-635.
12. Ng IO, Liang ZD, Cao L, Lee TK (2000) DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1. Cancer Res 60(23):6581-6584.
13. Peng D, Ren CP, Yi HM, et al. (2006) Genetic and epigenetic alterations of DLC-1, a candidate tumor suppressor gene, in nasopharyngeal carcinoma. Acta Biochim Biophys Sin (Shanghai) 38(5):349-355.
14. Pratesi C, Bortolin MT, Bidoli E, et al. (2006) Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immunother 55(1):23-30.
15. Seng TJ, Low JS, Li H, et al. (2007) The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation. Oncogene 26(6):934-944.
16. Song YF, Xu R, Zhang XH, et al. (2006) High frequent promoter hypermethylation of DLC-1 gene in multiple myeloma. J Clin Pathol 59(9):947-951.
17. Tao Q, Chan AT (2007) Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med 9(12):1-24.
18. Wang L, Ma J, Li J, et al. (2005) NGX6 gene inhibits cell proliferation and plays a negative role in EGFR pathway in nasopharyngeal carcinoma cells. J Cell Biochem 95(1):64-73.
19. Wilson PJ, McGlinn E, Marsh A, et al. (2000) Sequence variants of DLC1 in colorectal and ovarian tumours. Hum Mutat 15(2):156-165.
20. Xiong W, Zeng ZY, Li XL, et al. (2002) Single-nucleotide polymorphisms in NGX6 gene and their correlation with nasopharyngeal carcinoma. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 34(4):512-515.
21. Yi HM, Peng D, Zhang H, et al. (2006) Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma. Oncol Res 16(6):261-272.
22. Yuan BZ, Durkin ME, Popescu NC (2003) Promoter hypermethylation of DLC-1,a candidate tumor suppressor gene, in several common human cancers. Cancer Genet Cytogenet 140(2):113-117.
23. Yuan BZ, Jefferson AM, Baldwin KT, et al. (2004) DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas. Oncogene 23(7):1405-1411.
24. Yuan BZ, Miller MJ, Keck CL, et al. (1998) Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res 58(10):2196-2199.
25. Yuan BZ, Zhou X, Durkin ME, et al. (2003) DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity. Oncogene 22(3):445-450.
26. Zheng SL, Mychaleckyj JC, Hawkins GA, et al. (2003) Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study. Mutat Res 528(1-2):45-53.
27. Zhou L, Feng X, Shan W, et al. (2007a) Epigenetic and genetic alterations of the EDNRB gene in nasopharyngeal carcinoma. Oncology 72(5-6):357-363.
28. Zhou L, Jiang W, Ren C, et al. (2005) Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr Virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissues. Neoplasia 7(9):809-815.
29. Zhou W, Feng XL, Li H, et al. (2007b) Functional evidence for a nasopharyngeal carcinoma related gene BCAT1 located at 12p12. Oncol Res 16(9):405-413.